Nevada Governor Signs Diabetes Drug Price Transparency Bill into Law

Nevada’s landmark plan requiring insulin manufacturers to disclose price information was signed into law last week, establishing a more targeted strategy compared to the broader price transparency legislation currently being pursued in other states.
Source: Drug Industry Daily